IndustryTechCrunch·September 23, 2026
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
Enveda just secured $311 million to advance nature-derived AI drugs into clinical trials. This funding will accelerate their research and development efforts in creating innovative treatments from natural compounds.
More in Industry
IndustryLatent Space15h
[AINews] D-Day (Decision Models Day)
IndustryLatent Space15h
The Jev Revolution: What Engineers Are Already Building with System One Models
IndustryTechCrunch17h
Who could replace Jensen Huang? A highly unscientific list of possible successors
IndustryAWS Machine Learning19h